Loren E. Bonenclark, PA-C

Loren Bonenclark practices at Bold City Dermatology in Saint Augustine, Florida.

Loren Bonenclark's NPI, 1639629579, was assigned on October 4, 2016. Loren Bonenclark holds Florida license PA9112402.

Loren Bonenclark's primary practice is Bold City Dermatology, at 316 Paseo Reyes Dr, Saint Augustine, FL 32095-8464. The practice phone is (904) 544-5800.

Loren Bonenclark's primary practice is Bold City Dermatology in Saint Augustine, Florida. The medical group on file is Bold City Dermatology. Dmand AI also links Loren Bonenclark to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Loren Bonenclark practices. Vendor and product names are available with a free account.

Physician assistant is Loren Bonenclark's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Loren Bonenclark's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, minor injury on trunk, minor injury to a limb and psoriasis among the conditions Loren Bonenclark treats.

CMS data shows 819 Medicare services from Loren Bonenclark across 9 procedure codes in 2024, for 231 Medicare patients. Medicare paid $30,994 for them. Every service was in an office.

CMS counts 231 Medicare patients who saw Loren Bonenclark in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Loren Bonenclark's median patient age at 55, with 61% women.

In 2024, Loren Bonenclark wrote 167 Medicare Part D claims for 84 patients. 93% of them were for generic drugs. CMS names the drug for 109 of them, across 4 drugs with 11 or more claims each, at $2,074 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Loren Bonenclark for performance year 2024, reported as part of a group. Loren Bonenclark accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 20 general payments to Loren Bonenclark from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Organogenesis Inc. paid the most, $106.